The Platelet PGDprime test is now CE Marked and available for use outside the United States.
Verax Biomedical and Healthtrust® Purchasing Group Enter Agreement for the Use of the Verax Platelet PGD® Test
Verax Biomedical Announces Appointment of Paul D. Mintz, M.D. as Senior Vice President and Chief Medical Officer
Blood Centers of America and Verax Biomedical enter into Group Purchasing Agreement for the use of the Verax Platelet PGD® Test
CMS Issues Permanent P-Code P9100 Allowing Outpatient Hospital Billing of the Verax PGD® Test
FDA Clearances Allow Implementation of 7-Day Platelets in the U.S. with the Platelet PGD Test
Verax Biomedical Gains FDA Clearance for Expanded Platelet Safety Measure Testing Indications
FDA publishes Draft Guidance outlining need and approaches for testing platelets with rapid tests for bacterial contamination
Verax files 510 (k) for 2 additional platelet types, also modifies current product labeling
Verax Biomedical Closes $12MM Funding Round
The PGD testing system
The Company's first product is the Platelet PGD Test – a rapid test for the detection of bacterial contamination in platelets.